Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis

Medicine (United States)

Volumn 94, Issue 20, 2015, Pages

  Wu, Cho Kai ^a,b   Lee, Jen Kuang ^a,b   Wu, Yi Fan ^c   Tsai, Chia Ti ^a,b   Chiang, Fu Tien ^a,b   Hwang, Juey Jen ^a,b   Lin, Jiunn Lee ^a,b   Hung, Kuan Yu ^b   Huang, Jenq Wen ^b,c   Lin, Jou Wei ^a,c  

^a Division of Cardiology   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TISSUE DOPPLER IMAGING; ADVERSE EFFECTS; BLOOD; DIAGNOSIS; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ADIPOSE TISSUE; C-REACTIVE PROTEIN; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84937965579     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000819     Document Type: Article

References (33)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32 (5 suppl 3):S112-S119.
2. Lee JK, Lin HH, Tsai CT, et al. Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2012;22:974-980.
3. Bajraktari G, Berbatovci-Ukimeraj M, Hajdari A, et al. Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction. Croat Med J. 2009;50:543-549.
4. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton). 2006;11:36-41.
5. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003;16:85-94.
6. Wu CK, Huang YT, Lin HH, et al. Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients. PLoS One. 2013;8:e62722.
7. Wu CK, Yang CY, Lin JW, et al. The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling. Obesity (Silver Spring). 2012;20:730-737.
8. Lin HH, Lee JK, Yang CY, et al. Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis. Cardiovasc Diabetol. 2013;12:127.
9. Wu CK, Luo JL, Tsai CT, et al. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J. 2010;10:46-53.
10. Wu CK, Tsai CT, Chang YC, et al. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure. J Hypertens. 2009;27:502-507.
11. Wu CK, Tsai CT, Hwang JJ, et al. Renin-angiotensin system gene polymorphisms and diastolic heart failure. Eur J Clin Invest. 2008;38:789-797.
12. Greenland S. Hierarchical regression for epidemiologic analyses of multiple exposures. Environ Health Perspect. 1994;102 (suppl 8):33-39.
13. Zaslavsky LM, Pinotti AF, Gross JL. Diastolic dysfunction and mortality in diabetic patients on hemodialysis: a 4.25-year controlled prospective study. J Diabetes Complicat. 2005;19:194-200.
14. Vlasseros I, Katsi V, Vyssoulis G, et al. Aggravation of left ventricular diastolic dysfunction in hypertensives with coronary artery disease. Hypertens Res. 2013;36:885-888.
15. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
16. McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol. 2003;41:725-728.
17. Steinmetz OM, Panzer U, Stahl RA, et al. Statin therapy in patients with chronic kidney disease: to use or not to use. Eur J Clin Invest. 2006;36:519-527.
18. Ruiz-Del-Arbol L, Achecar L, Serradilla R, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatology. 2013;58:1732-1741.
19. de Heredia FP, Gomez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71:332-338.
20. Matsuzawa Y. The role of fat topology in the risk of disease. Int J Obes (Lond). 2008;32 (suppl 7):S83-S92.
21. Sanches FM, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis. 2008;52:66-73.
22. Yamauchi T, Kuno T, Takada H, et al. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2003;18:1842-1847.
23. Choi SJ, Kim EJ, Park MY, et al. Does body fat mass define survival in patients starting peritoneal dialysis? Perit Dial Int. 2014;34:376-382.
24. Lai KN, Leung JC. Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. Mediators Inflamm. 2010;2010:495416.
25. Nordfors L, Heimburger O, Lonnqvist F, et al. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int. 2000;57:1713-1719.
26. Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273-2282.
27. Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int. 2000;20 (suppl 3):S5-S96.
28. Kim DJ, Oh DJ, Kim B, et al. The effect of continuous ambulatory peritoneal dialysis on change in serum leptin. Perit Dial Int. 1999;19 (suppl 2):S172-S175.
29. Wolf G, Chen S, Han DC, et al. Leptin and renal disease. Am J Kidney Dis. 2002;39:1-11.
30. Pecoits-Filho R, Stenvinkel P, Wang AY, et al. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int. 2004;24:327-339.
31. Wu CK, Lee JK, Chiang FT, et al. Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2\+ ATPase. Crit Care Med. 2011;39:984-992.
32. Farshid A, Pathak R, Shadbolt B, et al. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol. 2013;14:280.
33. Kim JK, Kim SG, Kim MG, et al. Left ventricular diastolic dysfunction as a predictor of rapid decline of residual renal function in patients with peritoneal dialysis. J Am Soc Echocardiogr. 2012;25:411-420.